Objective: Gene expression alterations, especially in target tissues of insulin, have been associated with type 2 diabetes (T2D). In this study, we examined if genes involved in oxidative phosphorylation (OXPHOS) show differential gene expression and DNA methylation in pancreatic islets from patients with T2D compared with non-diabetic donors. Design and methods: Gene expression was analyzed in human pancreatic islets from 55 non-diabetic donors and nine T2D donors using microarray. Results: While the expected number of OXPHOS genes with reduced gene expression is 7.21, we identified 21 downregulated OXPHOS genes in pancreatic islets from patients with T2D using microarray analysis. This gives a ratio of observed over expected OXPHOS genes ...
Normal glucose homeostasis is characterized by appropriate insulin secretion and low HbA1c. Gene exp...
Objective: Genome wide association studies (GWAS) for type 2 diabetes (T2D) have identified genetic ...
Type 2 diabetes (T2D) is caused by insufficient insulin secretion from pancreatic β-cells. To identi...
OBJECTIVE: Gene expression alterations, especially in target tissues of insulin, have been associate...
The prevalence of type 2 diabetes (T2D) is increasing worldwide. T2D is a heterogeneous disease caus...
Islet dysfunction is central to the development and progression of type 2 diabetes (T2D). Epigenetic...
Background: Type 2 diabetes (T2D) is a complex disease characterised by chronic hyperglycaemia. The ...
Although several molecular pathways have been linked to type 2 diabetes (T2D) pathogenesis, it is un...
Introduction: Type 2 diabetes (T2D) is a multifactorial syndrome with beta-cell failure playing a ma...
Introduction: Type 2 diabetes (T2D) is a multifactorial syndrome with beta-cell failure playing a ma...
Type 2 diabetes (T2D) is caused by insufficient insulin secretion from pancreatic beta cells. To ide...
Impaired insulin secretion is a hallmark of type 2 diabetes (T2D). Epigenetics may affect disease su...
Genetic variation can modulate gene expression, and thereby phenotypic variation and susceptibility ...
Current knowledge about the role of epigenetics in type 2 diabetes (T2D) remains limited. Only a few...
[eng] Diabetes mellitus is a heterogeneous group of metabolic diseases characterized by impaired blo...
Normal glucose homeostasis is characterized by appropriate insulin secretion and low HbA1c. Gene exp...
Objective: Genome wide association studies (GWAS) for type 2 diabetes (T2D) have identified genetic ...
Type 2 diabetes (T2D) is caused by insufficient insulin secretion from pancreatic β-cells. To identi...
OBJECTIVE: Gene expression alterations, especially in target tissues of insulin, have been associate...
The prevalence of type 2 diabetes (T2D) is increasing worldwide. T2D is a heterogeneous disease caus...
Islet dysfunction is central to the development and progression of type 2 diabetes (T2D). Epigenetic...
Background: Type 2 diabetes (T2D) is a complex disease characterised by chronic hyperglycaemia. The ...
Although several molecular pathways have been linked to type 2 diabetes (T2D) pathogenesis, it is un...
Introduction: Type 2 diabetes (T2D) is a multifactorial syndrome with beta-cell failure playing a ma...
Introduction: Type 2 diabetes (T2D) is a multifactorial syndrome with beta-cell failure playing a ma...
Type 2 diabetes (T2D) is caused by insufficient insulin secretion from pancreatic beta cells. To ide...
Impaired insulin secretion is a hallmark of type 2 diabetes (T2D). Epigenetics may affect disease su...
Genetic variation can modulate gene expression, and thereby phenotypic variation and susceptibility ...
Current knowledge about the role of epigenetics in type 2 diabetes (T2D) remains limited. Only a few...
[eng] Diabetes mellitus is a heterogeneous group of metabolic diseases characterized by impaired blo...
Normal glucose homeostasis is characterized by appropriate insulin secretion and low HbA1c. Gene exp...
Objective: Genome wide association studies (GWAS) for type 2 diabetes (T2D) have identified genetic ...
Type 2 diabetes (T2D) is caused by insufficient insulin secretion from pancreatic β-cells. To identi...